Bipolar androgen therapy: a novel therapeutic strategy for castration-resistant prostate cancer
Hu, Y.-H.; Guo, J.-C.; Zhang, M.
Zhonghua Nan Ke Xue 23(12): 1138-1140
2017
ISSN/ISBN: 1009-3591 PMID: 29738189 Document Number: 692716
双极雄激素治疗（BAT）是去势抵抗性前列腺癌（CRPC）的新型治疗方法，可显著降低患者血清前列腺特异性抗原（PSA）水平，且具有良好的安全性。笔者结合近期国内外临床试验，对BAT提出的背景、机制、发展进程及前景作一综述。.
Document emailed within 1 workday
Related Documents
Bastos, D.A.; Dzik, C.; Rathkopf, D.; Scher, H.I. 2014: Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer Oncology 28(8): 693-699Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Bishr, M.; Lattouf, J.B.; Gannon, P.O.; Saad, F. 2011: Updates on therapeutic targets and agents in castration-resistant prostate cancer Minerva Urologica e Nefrologica 63(2): 131-143
Miyake, H.; Fujisawa, M. 2014: Antisense oligodeoxynucleotide therapy for castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2121-2125
Vázquez-Alonso, F.; Puche-Sanz, I.; Cózar-Olmo, J.é M. 2018: Recommendations for follow up in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 735-742
Naito, S.; Shiota, M. 2014: The concept and mechanisms of castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2090-2094
Rosino, A.; Ballester, I.; Tudela, J.án.; González-Billalabeitia, E. 2018: Chemotherapy in metastatic castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 676-684
Gomella, L.G.; Petrylak, D.P.; Shayegan, B. 2014: Current management of advanced and castration resistant prostate cancer Canadian Journal of Urology 21(2 Supp 1): 1-6
Ojeda, A.V.; Ledo, M.ía.J.é; Alvarez-Ossorio, J.é L.ís. 2018: Sequencing and combination of agents in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 711-720
Bourlon, M.T.; Glodé, L.M.; Crawford, E.D. 2014: Base of the skull metastases in metastatic castration-resistant prostate cancer Oncology 28(12): 1115-1116; 1124
Maeno, A.; Habuchi, T. 2016: Current status of castration-resistant prostate cancer translational research Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 40-44
Saitou, Y.; Hatanaka, Y.; Imanishi, M.; Ohzeki, T.; Hashimoto, K.; Sugimoto, K.; Esa, A.; Kajikawa, H.; Yasuda, M.; Yamamoto, Y.; Uemura, H. 2012: Analysis of prognostic factor in 52 castration-resistant prostate cancer treated with docetaxel Hinyokika Kiyo. Acta Urologica Japonica 58(1): 7-11
Wang, W.; Peng, R.-x.; Shi, G.-w.; Chen, S.-y.; Ding, Q.; He, J.-y. 2015: Treatment of castration-resistant prostate cancer: Evidence-based clinical practice Zhonghua Nan Ke Xue 21(12): 1121-1124
Hakariya, T.; Sakai, H. 2016: Efficacy and problems of new hormonal agents for the treatment of castration resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 137-142
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319
Bejrananda, T.; Pripatnanont, C.; Tanthanuch, M.; Karnjanawanichkul, W. 2016: Oncological Outcome of Docetaxel-Based Chemotherapy for Men with Metastatic Castration-Resistant Prostate Cancer Journal of the Medical Association of Thailand 99(12): 1315-1321
Ecstein-Fraisse, E.; Su, Z. 2014: Cabazitaxel--a next-generation taxane for the treatment of patients with metastatic castration-resistant prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(7): 817-822
Zhang, Y.; Lei, B.-H.; Zou, Q.; Zhu, Q.-Y.; Lu, Z.-J.; Wang, Y. 2017: Clinical efficacy of integrated traditional Chinese and Western medicine for castration-resistant prostate cancer Zhonghua Nan Ke Xue 23(10): 922-927
Azuma, K.; Kawakami, K.; Yuasa, T.; Sugisaki, T.; Hashimoto, K.; Aoyama, T.; Suzuki, K.; Yonese, J.; Hama, T. 2018: Safety Profile of the Combination of Prophylactic Pegfilgrastim and Cabazitaxel for Japanese Patients with Castration Resistant Prostate Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(12): 1737-1742
Kageyama, S.; Iwaki, H.; Masuda, Y.; Yoshida, T.; Narita, M.; Okada, Y. 2011: Long-term disease stabilization by docetaxel plus estramustine for castration-resistant prostate cancer : report of a case Hinyokika Kiyo. Acta Urologica Japonica 57(4): 203-207